company background image
BSX logo

Boston Scientific NYSE:BSX Stock Report

Last Price

US$77.41

Market Cap

US$113.4b

7D

2.0%

1Y

45.2%

Updated

12 Jun, 2024

Data

Company Financials +

Boston Scientific Corporation

NYSE:BSX Stock Report

Market Cap: US$113.4b

BSX Stock Overview

Develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.

BSX fundamental analysis
Snowflake Score
Valuation0/6
Future Growth3/6
Past Performance4/6
Financial Health4/6
Dividends0/6

Narratives

Beta

Narratives bring a range of perspectives from our community.

Boston Scientific Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Boston Scientific
Historical stock prices
Current Share PriceUS$77.41
52 Week HighUS$77.64
52 Week LowUS$48.35
Beta0.81
1 Month Change6.32%
3 Month Change15.78%
1 Year Change45.21%
3 Year Change80.95%
5 Year Change85.81%
Change since IPO1,708.12%

Recent News & Updates

Why We're Not Concerned About Boston Scientific Corporation's (NYSE:BSX) Share Price

Jun 08
Why We're Not Concerned About Boston Scientific Corporation's (NYSE:BSX) Share Price

Is Boston Scientific (NYSE:BSX) Using Too Much Debt?

May 10
Is Boston Scientific (NYSE:BSX) Using Too Much Debt?

Recent updates

Why We're Not Concerned About Boston Scientific Corporation's (NYSE:BSX) Share Price

Jun 08
Why We're Not Concerned About Boston Scientific Corporation's (NYSE:BSX) Share Price

Is Boston Scientific (NYSE:BSX) Using Too Much Debt?

May 10
Is Boston Scientific (NYSE:BSX) Using Too Much Debt?

Boston Scientific (NYSE:BSX) Is Reinvesting At Lower Rates Of Return

Apr 22
Boston Scientific (NYSE:BSX) Is Reinvesting At Lower Rates Of Return

Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash

Apr 05

A Look At The Fair Value Of Boston Scientific Corporation (NYSE:BSX)

Mar 26
A Look At The Fair Value Of Boston Scientific Corporation (NYSE:BSX)

We Ran A Stock Scan For Earnings Growth And Boston Scientific (NYSE:BSX) Passed With Ease

Feb 29
We Ran A Stock Scan For Earnings Growth And Boston Scientific (NYSE:BSX) Passed With Ease

What You Can Learn From Boston Scientific Corporation's (NYSE:BSX) P/E

Feb 15
What You Can Learn From Boston Scientific Corporation's (NYSE:BSX) P/E

Is Boston Scientific (NYSE:BSX) A Risky Investment?

Feb 02
Is Boston Scientific (NYSE:BSX) A Risky Investment?

Boston Scientific (NYSE:BSX) Could Be Struggling To Allocate Capital

Jan 19
Boston Scientific (NYSE:BSX) Could Be Struggling To Allocate Capital

Boston Scientific: Portfolio Updates Driving Top-Line Growth

Jan 17

Boston Scientific: Continued M&A Drives More Growth

Jan 10

Is Boston Scientific Corporation (NYSE:BSX) Worth US$56.1 Based On Its Intrinsic Value?

Dec 04
Is Boston Scientific Corporation (NYSE:BSX) Worth US$56.1 Based On Its Intrinsic Value?

Does Boston Scientific (NYSE:BSX) Have A Healthy Balance Sheet?

Nov 03
Does Boston Scientific (NYSE:BSX) Have A Healthy Balance Sheet?

Boston Scientific: Delivering Strong Growth, But Sector Derating Is A Big Issue

Oct 30

ADVENT Offers Up An Early Present For Boston Scientific Investors

Aug 28

Estimating The Fair Value Of Boston Scientific Corporation (NYSE:BSX)

Aug 24
Estimating The Fair Value Of Boston Scientific Corporation (NYSE:BSX)

Boston Scientific (NYSE:BSX) Seems To Use Debt Quite Sensibly

Jul 25
Boston Scientific (NYSE:BSX) Seems To Use Debt Quite Sensibly

Boston Scientific Remains Operationally Sound But May Have Limited Upside

Jul 14

Investors Could Be Concerned With Boston Scientific's (NYSE:BSX) Returns On Capital

Jul 10
Investors Could Be Concerned With Boston Scientific's (NYSE:BSX) Returns On Capital

Boston Scientific Corporation (NYSE:BSX) Shares Could Be 29% Above Their Intrinsic Value Estimate

May 21
Boston Scientific Corporation (NYSE:BSX) Shares Could Be 29% Above Their Intrinsic Value Estimate

Here's Why Boston Scientific (NYSE:BSX) Can Manage Its Debt Responsibly

Apr 18
Here's Why Boston Scientific (NYSE:BSX) Can Manage Its Debt Responsibly

Returns On Capital At Boston Scientific (NYSE:BSX) Paint A Concerning Picture

Apr 03
Returns On Capital At Boston Scientific (NYSE:BSX) Paint A Concerning Picture

Boston Scientific Stands Out With Strong, Diversified Growth Profile

Feb 15

Boston Scientific Non-GAAP EPS of $0.45 misses by $0.02, revenue of $3.24B in-line

Feb 01

Boston Scientific sees double digit EPS growth in 2023 - JPMorgan Healthcare conference

Jan 11

Boston Scientific to acquire majority stake of Acotec Scientific

Dec 12

Shareholder Returns

BSXUS Medical EquipmentUS Market
7D2.0%0.5%1.0%
1Y45.2%1.7%21.8%

Return vs Industry: BSX exceeded the US Medical Equipment industry which returned 1.7% over the past year.

Return vs Market: BSX exceeded the US Market which returned 21.8% over the past year.

Price Volatility

Is BSX's price volatile compared to industry and market?
BSX volatility
BSX Average Weekly Movement2.5%
Medical Equipment Industry Average Movement7.8%
Market Average Movement5.8%
10% most volatile stocks in US Market15.6%
10% least volatile stocks in US Market2.9%

Stable Share Price: BSX has not had significant price volatility in the past 3 months.

Volatility Over Time: BSX's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
197948,000Mike Mahoneywww.bostonscientific.com

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system.

Boston Scientific Corporation Fundamentals Summary

How do Boston Scientific's earnings and revenue compare to its market cap?
BSX fundamental statistics
Market capUS$113.42b
Earnings (TTM)US$1.77b
Revenue (TTM)US$14.71b

64.5x

P/E Ratio

7.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BSX income statement (TTM)
RevenueUS$14.71b
Cost of RevenueUS$4.56b
Gross ProfitUS$10.15b
Other ExpensesUS$8.38b
EarningsUS$1.77b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.20
Gross Margin69.00%
Net Profit Margin12.00%
Debt/Equity Ratio52.6%

How did BSX perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.